Xencor, Inc.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Xencor, Inc.
RECRUITINGPhase 1NCT05433142
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear...
Sponsor: Xencor, Inc.Enrolling: 30720 locations
Clear Cell Renal Cell Carcinoma
RECRUITINGPhase 1 / Phase 2NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Brief summary The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B)....
Sponsor: Xencor, Inc.Enrolling: 27020 locations
Ulcerative Colitis (UC)